Earnings Call · Q3 FY2022·2022-11-02

Q3 22EPS +4.17%·Rev n/aQ2 22EPS -2.86%·Rev n/aQ1 22EPS +21.95%·Rev n/aQ4 21EPS -48.98%·Rev n/a⚠ consensus missing

Aquestive Therapeutics, Inc. AQST

Bennett Watson — Investor Relations or Corporate Communications

Dan Barber — Chief Executive Officer

Ernie Toth — Chief Financial Officer

−1.8%1d on move date+0.7% vs SPY3d+2.3%5d+6.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AQST calls or request research access.

More AQST calls Browse calls Request research access